Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Biological Safety Cabinet Market size was valued at USD 1.21 billion in 2024 and is expected to reach USD 4.33 billion by 2037, registering around 10.3% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of biological safety cabinet is assessed at USD 1.31 billion.
The BSC market is a rapidly growing sector within the life sciences industry. Biological Safety Cabinets are used in various applications such as research and development, clinical testing, and manufacturing. These cabinets are designed to provide a safe and controlled environment for handling biological materials and preventing the spread of infectious agents. The regulatory bodies have imposed strict guidelines and regulations for laboratory safety, which mandate the use of biological safety cabinets.
The biological safety cabinet market is expected to grow significantly in the coming years owing to the increasing demand for safe laboratory practices, the growth of the biotechnology and pharmaceutical industries, and increasing research activities in the fields of microbiology and genetics. Additionally, the COVID-19 pandemic has further increased the demand for biosafety cabinets, as they are essential in preventing the spread of infectious diseases. The rising incidence of infectious diseases such as COVID-19 has led to an increase in the demand for biosafety cabinets. According to the World Health Organization (WHO), there were over 172 million confirmed cases of COVID-19 globally as of May 2021.
Biological Safety Cabinet Market: Growth Drivers and Challenges
Growth Drivers
- Increasing Incidence of Infectious Diseases: Tuberculosis (TB) is a bacterial infection that primarily affects the lungs. According to the WHO, there were an estimated 10 million cases of TB worldwide in 2020, with 1.5 million deaths. The COVID-19 pandemic has significantly impacted the world, with over 466 million confirmed cases and over 6.1 million deaths globally as of November 2021, according to the World Health Organization (WHO). Human immunodeficiency virus (HIV) is a virus that attacks the immune system, and acquired immunodeficiency syndrome (AIDS) is the most advanced stage of HIV infection. According to UNAIDS, there were approximately 38 million people living with HIV/AIDS globally in 2020, with 680,000 deaths.
- Increasing Awareness about Laboratory Safety: The increasing awareness about laboratory safety and the need to prevent the spread of infectious diseases is driving the demand for biological safety cabinets. According to a survey by the Centers for Disease Control and Prevention (CDC), 73% of laboratory workers reported taking precautions to avoid exposure to infectious agents.
- Growing Demand for Gene Editing and Cell Therapy Research: The increasing demand for gene editing and cell therapy research is driving the growth of the biological safety cabinet market. According to a report, the global cell industry accounted for nearly USD 7.5 billion in 2020.
- Rise in Research Spending – Growth in the global market during the forecast period can be further attributed to increased investment in research and development activities to continuously find more viable solutions for biological safety cabinets. Research reports show that global R&D spending has more than tripled in real terms since 2000, rising from about USD 680 billion to more than USD 2.5 trillion in the year 2019.
- Spiking Healthcare Spending – According to the latest spending data, global healthcare spending has increased over the past two decades, effectively doubling from 8.5% in 2000 to USD 8.5 trillion in the year 2019, increasing GDP reached 9.8%. The boom will continue during the forecast period.
Challenges
- High cost: Biological safety cabinets are expensive, and their high cost can be a significant barrier to adoption, especially for smaller laboratories and research institutions.
- Complexity and maintenance
- Lack of awareness and training
Biological Safety Cabinet Market: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
10.3% |
|
Base Year Market Size (2024) |
USD 1.21 billion |
|
Forecast Year Market Size (2037) |
USD 4.33 billion |
|
Regional Scope |
|
Biological Safety Cabinet Segmentation
End User (Pharma & Biopharma Companies, Hospitals, and Diagnostics & Testing Laboratories)
The hospital segment is estimated to hold 35% share of the global biological safety cabinet market by 2037. This growth is attributed to the large number of patients present in hospital facilities for treatment. The number of hospitals is also notably growing. For instance, by the year 2022, there were noted to be approximately 6,100 hospitals in the United States. Hospitals provide a wide range of medical care. Physicians, called hospital doctors, typically specialize in internal medicine, pediatrics, or general practice. They have the knowledge to solve common problems and the resources to solve more complex medical problems. Hospitals may also offer specialized care, such as neurology, obstetrics and gynecology, and oncology. By definition of a hospital, a county hospital is typically a primary medical facility in a region with numerous intensive care and mobile beds for patients requiring long-term care.
Application (Industrial, R & D, Academic)
The industrial segment is expected to garner a significant share of around 30% in the year 2037. The growth of the segment can be accredited to the increasing demand for biopharmaceuticals in the industry. The global demand for biopharmaceuticals is increasing rapidly, and this is driving the growth of the industrial segment in the biological safety cabinet market. Biopharmaceuticals are produced using living cells, which require a sterile and controlled environment to ensure their safety and efficacy. Biological safety cabinets provide an essential tool for maintaining this environment, and the increasing demand for biopharmaceuticals is driving the demand for biological safety cabinets. The biopharmaceutical industry is subject to strict regulatory guidelines, and compliance with these guidelines is critical for the safety and efficacy of biopharmaceutical products. Biological safety cabinets are an essential tool for maintaining the required levels of sterility and safety, and their use is mandated by regulatory bodies such as the FDA and EMA. The stringent regulatory guidelines are driving the demand for biological safety cabinets in the industrial segment. The industrial segment is investing heavily in research and development to drive innovation and growth. Biological safety cabinets are an essential tool for R&D activities, providing a safe and controlled environment for the development and testing of new products. As companies continue to invest in R&D, the demand for biological safety cabinets is expected to increase.
Our in-depth analysis of the global market includes the following segments:
|
By End User |
|
|
By Application |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportBiological Safety Cabinet Industry - Regional Synopsis
Asia Pacific Market Statistics
The biological safety cabinets in the Asia Pacific is projected to hold the largest revenue share of about 35% by the end of 2037. The regional growth can majorly be attributed to the increasing investment in life sciences research in the region. The Asia Pacific region is experiencing rapid growth in life sciences research, driven by government investments and private sector initiatives. This growth is creating a demand for advanced laboratory equipment, including biological safety cabinets, to support research activities. The Asia Pacific region has seen an increase in awareness about laboratory safety in recent years, with governments and industry bodies promoting best practices in laboratory safety. This has led to an increased demand for biological safety cabinets to ensure the safety of laboratory workers and maintain the integrity of research. The Asia Pacific Biosafety Association (APBA) is a regional organization that promotes biosafety and biosecurity awareness in the Asia Pacific region. The APBA has over 1,000 members from 20 countries in the region, which is a testament to the increasing awareness about laboratory safety in the region.
North American Market Statistics
The North America biological safety cabinet market is anticipated to hold around 24% of the revenue share by 2037. The growth of the market in this region can primarily be attributed to the increasing focus on biosafety in the region. There is a growing focus on biosafety in the North America region, driven by the increasing incidence of infectious diseases and biosecurity threats. This is leading to an increased demand for biological safety cabinets to ensure the safety of laboratory workers and prevent the spread of infectious diseases. The North America region has some of the most stringent regulations related to laboratory safety, which is driving the demand for biological safety cabinets. The Occupational Safety and Health Administration (OSHA) and the National Institutes of Health (NIH) have set strict guidelines for laboratory safety, which include the use of biological safety cabinets. The North America region is home to some of the world's largest manufacturers of laboratory equipment, including biological safety cabinets. The presence of these key market players is driving the growth of the market in the region.
Top Featured Companies Dominating the Global Biological Safety Cabinet Market
- Thermo Fisher Scientific Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Esco Micro Pte Ltd.
- Labconco Corporation
- NuAire, Inc.
- The Baker Company, Inc.
- Kewaunee Scientific Corporation
- BIOBASE Group
- Germfree Laboratories Inc.
- Azbil Telstar, S.L.
- Erlab Group
In the News
- Thermo Fisher Scientific Inc.: Thermo Fisher Scientific announced that it had entered into an agreement to acquire PPD, a leading global provider of clinical research services, for $17.4 billion. This acquisition will expand Thermo Fisher's offerings in the healthcare and life sciences industries, including in the areas of drug discovery and development.
- Esco Micro Pte Ltd.: Esco Micro announced that it had received ISO 9001:2015 certification for its Quality Management System. This certification recognizes Esco Micro's commitment to providing high-quality products and services to its customers in the life sciences industry. Esco Micro is a leading manufacturer of laboratory equipment, including biological safety cabinets.
Author Credits: Radhika Pawar
- Report ID: 5007
- Published Date: Nov 08, 2024
- Report Format: PDF, PPT
